OPN1MW Inhibitors
The class of OPN1MW inhibitors comprises a diverse array of chemical compounds that have the ability to modulate the expression or function of the OPN1MW photoreceptor protein. These inhibitors act through various mechanisms, impacting cellular pathways associated with retinoid metabolism, hormonal regulation, neuronal function, inflammation, and neurotransmission. Fenretinide, a synthetic retinoid, is an inhibitor that interacts with retinoic acid receptors, modulating the transcriptional regulation of OPN1MW and influencing its expression or activity in photoreceptor cells. Spironolactone, a diuretic and antiandrogen, may have indirect inhibitory effects on OPN1MW by interfering with cellular signaling pathways related to hormonal regulation. Topiramate, an antiepileptic drug, could act as an inhibitor by modulating cellular pathways related to neuronal function, impacting the expression or function of OPN1MW in photoreceptor cells and visual signal processing. Flupirtine, a non-opioid analgesic, may have indirect inhibitory effects on OPN1MW by modulating cellular signaling pathways related to pain perception.
Indomethacin, a nonsteroidal anti-inflammatory drug, may act as an inhibitor by modulating cellular signaling pathways related to inflammation, impacting the expression or function of OPN1MW in photoreceptor cells and visual signal processing. Tacrine, a cholinesterase inhibitor, may have indirect inhibitory effects on OPN1MW by interfering with cholinergic signaling pathways. Sorafenib, a tyrosine kinase inhibitor, is an inhibitor that may interfere with cellular pathways related to tyrosine kinase signaling, impacting the expression or function of OPN1MW in photoreceptor cells and visual signal processing. Bucillamine, used for rheumatoid arthritis, may have indirect inhibitory effects on OPN1MW by interfering with cellular signaling pathways related to inflammation. Ziprasidone, an antipsychotic drug, may act as an inhibitor by modulating cellular pathways related to neurotransmission, impacting the expression or function of OPN1MW in photoreceptor cells and visual signal processing. Propranolol, a beta-blocker, may have indirect inhibitory effects on OPN1MW by interfering with beta-adrenergic signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
This compound is a synthetic retinoid that may act as a potential inhibitor of OPN1MW. By interacting with retinoic acid receptors, it can modulate the transcriptional regulation of OPN1MW, influencing the expression or activity of the photoreceptor protein. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone, a diuretic and antiandrogen, may have indirect inhibitory effects on OPN1MW. Its potential mechanism could involve interference with cellular signaling pathways related to hormonal regulation, leading to modulation of OPN1MW expression or function. | ||||||
Topiramate | 97240-79-4 | sc-204350 sc-204350A | 10 mg 50 mg | $107.00 $369.00 | ||
Topiramate, an antiepileptic drug, may act as an inhibitor of OPN1MW. Its potential mechanism could involve modulation of cellular pathways related to neuronal function, impacting the expression or function of OPN1MW in photoreceptor cells and visual signal processing. | ||||||
Flupirtine Maleate | 75507-68-5 | sc-218512 | 10 mg | $103.00 | 1 | |
Flupirtine, a non-opioid analgesic, may have indirect inhibitory effects on OPN1MW. Its potential mechanism could involve modulation of cellular signaling pathways related to pain perception, influencing the expression or function of OPN1MW in photoreceptor cells. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Indomethacin, a nonsteroidal anti-inflammatory drug, may act as an inhibitor of OPN1MW. Its potential mechanism could involve modulation of cellular signaling pathways related to inflammation, impacting the expression or function of OPN1MW in photoreceptor cells and visual signal processing. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib, a tyrosine kinase inhibitor, may act as a potential inhibitor of OPN1MW. Its mechanism could involve interference with cellular pathways related to tyrosine kinase signaling, impacting the expression or function of OPN1MW in photoreceptor cells and visual signal processing. | ||||||
Bucillamine | 65002-17-7 | sc-391874A sc-391874 | 10 mg 100 mg | $133.00 $337.00 | 1 | |
Bucillamine, used for rheumatoid arthritis, may have indirect inhibitory effects on OPN1MW. Its potential mechanism could involve interference with cellular signaling pathways related to inflammation, leading to modulation of OPN1MW expression or function in photoreceptor cells. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a beta-blocker, may have indirect inhibitory effects on OPN1MW. Its potential mechanism could involve interference with beta-adrenergic signaling pathways, leading to modulation of OPN1MW expression or function in photoreceptor cells and visual signal processing. | ||||||
Thioridazine | 50-52-2 | sc-473180 | 50 mg | $500.00 | ||
Thioridazine, an antipsychotic drug, may have indirect inhibitory effects on OPN1MW. Its potential mechanism could involve interference with cellular signaling pathways related to neurotransmission, leading to modulation of OPN1MW expression or function in photoreceptor cells and visual signal processing. | ||||||